Pharmakologie, Toxikologie und Klinische Pharmazie



Dong M, Mürdter TE, Philippi C, Loretz B, Schaefer UF, Lehr CM, Schwab M, Ammon-Treiber S (2012)

Pulmonary delivery and tissue distribution of aerosolized antisense 2'-O-Methyl RNA containing nanoplexes in the isolated perfused and ventilated rat lung. Eur J Pharm Biopharm; 81(3): 478-85.

Dong M, Philippi C, Loretz B, Nafee N, Schaefer UF, Ammon-Treiber S, Griese EU, Lehr CM, Klotz U, Mürdter TE (2011)

Tissue slice model of human lung cancer to investigate telomerase inhibition by nanoparticle delivery of antisense 2’-O-methyl-RNA. Int J Pharm; 419 (1-2)

Ammon-Treiber S, Grecksch G, Angelidis C, Vezyraki P, Höllt V, Becker A. (2008)

Emotional and learning behaviour in mice overexpressing heat shock protein 70. Neurobiol Learn Mem. 90(2):358-364.

Ammon-Treiber S, Stolze D, Höllt V (2007)

Differential effects of mu-opioid receptor agonists in a hippocampal hypoxia/hypoglycemia model. Brain Res. 1183:60-65.

Ammon-Treiber S, Grecksch G, Angelidis C, Vezyraki P, Höllt V, Becker A (2007) Pentylenetetrazol-kindling in mice overexpressing heat shock protein 70. Naunyn Schmiedebergs Arch Pharmacol 375 (2): 115-121

Ammon-Treiber S, Stolze D, Schröder H, Loh H, Höllt V (2005)

Effects of opioid antagonists and morphine in a hippocampal hypoxia/hypoglycemia model. Neuropharmacology 49: 1160-1169

Ammon-Treiber S, Grecksch G, Stumm R, Riechert U, Tischmeyer H, Reichenauer A, Höllt V (2004)

Rapid, transient, and dose-dependent expression of Hsp70 messenger RNA in the rat brain after morphine treatment. Cell Stress Chaperones 9(2): 182-197

Ammon-Treiber S, Tischmeyer H, Riechert U, Höllt V (2004)

Gene expression of transcription factors in the rat brain after morphine withdrawal. Neurochem Res 29 (6): 1267-1273

Treiber G, Schwabe M, Ammon S, Walker S, Klotz U, Malfertheiner P (2004)

Dyspeptic symptoms associated with Helicobacter pylori infection are influenced by strain and host specific factors. Aliment Pharmacol Ther 19 (2): 219-231

Ammon S, Mayer P, Riechert U, Tischmeyer H, Höllt V (2003)

Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal. Mol Brain Res 112: 113 - 125

Mayer P, Ammon S, Braun H, Tischmeyer H, Riechert U, Kahl E, Höllt V (2002) Gene expression profile after intense second messenger activation in cortical primary neurons. J Neurochem 82 (5): 1077 - 1086

Mayer P, Erdtmann-Vourliois M, Riechert U, Ammon S, Höllt V (2002)

Mild stress sensitizes the brain's response to morphine. Mol Brain Res 104 (2): 143-147

Treiber G, Ammon S, Malfertheiner P, Klotz U (2002)

Impact of furazolidone based quadruple therapy for eradication of Helicobacter pylori after previous treatment failures. Helicobacter 7(4): 225 - 231

Ammon S, Marx C, Behrens C, Hofmann U, Murdter T, Griese EU, Mikus G (2002)

Diclofenac does not interact with codeine metabolism in vivo: A study in healthy volunteers. BMC Clin Pharmacol 2 (1):2

Treiber G, Wittig J, Ammon S, Walker S, Kees F, van Doorn LJ, Klotz U (2002)

Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study). Arch Intern Med 162(2): 153-60

Erdtmann-Vourliotis M, Mayer P, Riechert U, Ammon S, Höllt V (2001)

Distribution of the G-protein-coupled receptor kinases 2,3,5 and 6 mRNA in the rat brain Mol Brain Res 95 (1-2): 129-137

Schwab M, Röder F, Aleker T, Ammon S, Thon KP, Eichelbaum M, Klotz U (2000)

Psychotropic drug use, falls and hip fracture in the elderly. Aging Clin Exp Res 12 (3): 234-239

Ammon S, von Richter O, Hofmann U, Thon KP, Eichelbaum M, Mikus G (2000)

In vitro interaction of codeine and diclofenac. Drug Metab Dispos 28 (10): 1149-1152

Eckhardt K, Ammon S, Hofmann U, Riebe A, Gugeler N, Mikus G (2000)

Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg 91 (1): 185-191

Ammon S, Treiber G, Kees F, Klotz U (2000)

Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 14 (6): 759-766

Treiber G, Ammon S, Klotz U (1999)

5-Day H. pylori eradication. Aliment Pharmacol Ther 13 (9): 1252-1253 (Letter)

Ammon S, Hofmann U, Griese EU, Gugeler N, Mikus G (1999)

Pharmacokinetics of dihydrocodeine and its active metabolite after single and multiple oral dosing. Br J Clin Pharmacol 48 (3): 317-322

Schwab M, Röder F, Ammon S, Thon KP, Mörike K (1999)

Increased number of hip fractures. The Lancet 353 (9170): 2160

Eckhardt K, Li S, Ammon S, Schänzle G, Mikus G, Eichelbaum M (1998)

Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation. Pain 76 (1-2): 27 – 33

Treiber G, Ammon S, Schneider E, Klotz U (1998)

Amoxicillin/Metronidazole/Omeprazole/Clarithromycin: A new short quadruple therapy for Helicobacter pylori eradication. Helicobacter 3 (1): 54 – 58

Treiber G, Ammon S, Klotz U (1997)

Age – dependent eradication of Helicobacter pylori with dual therapy. Aliment Pharmacol Ther 11 (14): 711 – 718

Muller CP, Bünder R, Mayser H, Ammon S, Weinmann M, Brons NHC, Schneider F, Jung G, Wiesmüller KH (1995)

Intramolecular immunodominance and intermolecular selection of H2d- restricted peptides define the same immunodominant region of the measles virus fusion protein

Molec Immunol 32 (1): 37 – 47


Ammon-Treiber S & Höllt V (2005)

Morphine induced gene expression. Addict Biol 10 (1): 81-89